Article Type
Editorial
Published
This editorial introduces the special series in Drugs in Context that explores treatment advancements for endometrial cancer through clinical case studies.
Insights from real-world clinical experiences in Italian oncology centres.
Editorial
This editorial introduces the special series in Drugs in Context that explores treatment advancements for endometrial cancer through clinical case studies.
Case Report
This article presents a case demonstrating the use of combination immunotherapy with pembrolizumab and lenvatinib in a patient with recurrent and metastatic endometrial cancer.
Case Report
This article describes the case of a woman with deficient mismatch repair/microsatellite instability endometrial cancer who did not respond to first-line treatment with carboplatin and paclitaxel but had a high response to subsequent immunotherapy with dostarlimab.
Case Report
A clinical case report with a favourable outcome aiming to compare the patient’s response and tolerability with efficacy and toxicity data reported in clinical studies.
Case Report
This article presents a case of advanced mismatch repair proficiency/microsatellite stable endometrial carcinoma that was successfully treated with pembrolizumab plus lenvatinib
after chemotherapy failure.